Cancer Pain Market Share, Size, Symptoms, Treatment, Global Insights, Analysis and Pipeline Review, H1 2016

Transcription

Cancer Pain Market Share, Size, Symptoms, Treatment, Global Insights, Analysis and Pipeline Review, H1 2016
Cancer Pain Market Share, Analysis and Pipeline Review, H1
2016 by Radiant Insights
Summary
Global Markets Direct's, 'Cancer Pain - Pipeline Review, H1 2016', provides an overview of the Cancer Pain pipeline
landscape.
The report provides comprehensive information on the therapeutics under development for Cancer Pain, complete
with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases. Additionally, the report provides an
overview of key players involved in therapeutic development for Cancer Pain and features dormant and
discontinued projects.
View Full Report with TOC @ http://www.radiantinsights.com/research/cancer-pain-pipeline-review-h1-2016
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party sources.
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision
making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the global therapeutic landscape of Cancer Pain
- The report reviews pipeline therapeutics for Cancer Pain by companies and universities/research institutes based
on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description,
descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Cancer Pain therapeutics and enlists all their major and minor projects
- The report assesses Cancer Pain therapeutics based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Cancer Pain
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Cancer Pain
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Cancer Pain pipeline depth and focus of
Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove
them from pipeline
Request Sample Copy of This Report @ http://www.radiantinsights.com/research/cancer-pain-pipeline-reviewh1-2016/request-sample
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 10
Introduction 11
Global Markets Direct Report Coverage 11
Cancer Pain Overview 12
Therapeutics Development 13
Pipeline Products for Cancer Pain - Overview 13
Pipeline Products for Cancer Pain - Comparative Analysis 14
Cancer Pain - Therapeutics under Development by Companies 15
Cancer Pain - Therapeutics under Investigation by Universities/Institutes 17
Cancer Pain - Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Cancer Pain - Products under Development by Companies 22
Cancer Pain - Products under Investigation by Universities/Institutes 24
Cancer Pain - Companies Involved in Therapeutics Development 25
AngioChem Inc. 25
Aphios Corporation 26
AstraZeneca Plc 27
BCN Peptides, S.A. 28
Benitec Biopharma Limited 29
BioDelivery Sciences International, Inc. 30
ChironWells GmbH 31
Daewoong Pharmaceutical Co., Ltd. 32
Daiichi Sankyo Company, Limited 33
Fujimoto Pharmaceutical Corporation 34
Grunenthal GmbH 35
GW Pharmaceuticals Plc 36
Hisamitsu Pharmaceutical Co., Inc. 37
Immupharma Plc 38
IntelGenx Corp. 39
Kineta, Inc. 40
View Full Report with TOC @ http://www.radiantinsights.com/research/cancer-pain-pipeline-review-h1-2016
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence
requirements. We assist and facilitate organizations and individuals procure market research reports, helping them
in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries
and a host of micro markets. In addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research
solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: [email protected]
Visit our Blog: http://chemicalsandmaterialsri.blogspot.com

Similar documents

Constipation Market Treatment, Statistics, Share, Pipeline Review, H1 2016

Constipation Market Treatment, Statistics, Share, Pipeline Review, H1 2016 The report provides comprehensive information on the therapeutics under development for Constipation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Visit us @ http://www.radiantinsights.com/research/constipation-pipeline-review-h1-2016

More information

Colitis Market Treatment, Size, Share, Pipeline Review, H1 2016: Radiant Insights

Colitis Market Treatment, Size, Share, Pipeline Review, H1 2016: Radiant Insights The report provides comprehensive information on the therapeutics under development for Colitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Read More @ http://www.radiantinsights.com/research/colitis-pipeline-review-h1-2016

More information

Global Atherosclerosis Market Growth And Forecast Report To 2015: Radiant Insights, Inc

Global Atherosclerosis Market Growth And Forecast Report To 2015: Radiant Insights, Inc Atherosclerosis - Pipeline Review, H2 2015', provides an overview of the Atherosclerosis's therapeutic pipeline.. Read More @ http://www.radiantinsights.com/research/atherosclerosis-pipeline-review-h2-2015

More information

Stroke Market Size, Causes, Outlook, Overview and Pipeline Review, H1 2016

Stroke Market Size, Causes, Outlook, Overview and Pipeline Review, H1 2016 Global Markets Direct's, 'Stroke - Pipeline Review, H1 2016', provides an overview of the Stroke pipeline landscape. Read more @ http://www.radiantinsights.com/research/stroke-pipeline-review-h1-2016

More information

Acute Lung Injury Market Size, Symptoms, Treatment, Causes, Analysis, Overview and Pipeline Review, H1 2016

Acute Lung Injury Market Size, Symptoms, Treatment, Causes, Analysis, Overview and Pipeline Review, H1 2016 Global Markets Direct's, 'Acute Lung Injury - Pipeline Review, H1 2016', provides an overview of the Acute Lung Injury pipeline landscape. Read More @ http://www.radiantinsights.com/research/acute-lung-injury-pipeline-review-h1-2016

More information

Schizophrenia Market Share, Size, Growth, Analysis, Overview and Pipeline Review, H1 2016

Schizophrenia Market Share, Size, Growth, Analysis, Overview and Pipeline Review, H1 2016 Global Markets Direct's, 'Schizophrenia - Pipeline Review, H1 2016', provides an overview of the Schizophrenia pipeline landscape. Visit us @ http://www.radiantinsights.com/research/schizophrenia-pipeline-review-h1-2016

More information

Amyloidosis Market Share, Size, Treatment, Symptoms, Crisis, Causes, Pipeline Review, H2 2016

Amyloidosis Market Share, Size, Treatment, Symptoms, Crisis, Causes, Pipeline Review, H2 2016 The report provides comprehensive information on the therapeutics under development for Amyloidosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

More information

Influenza B Infections Market Share, Size, Definition, Crisis, Causes, Pipeline Review, H2 2016

Influenza B Infections Market Share, Size, Definition, Crisis, Causes, Pipeline Review, H2 2016 Global Markets Direct's, 'Influenza B Infections - Pipeline Review, H2 2016', provides an overview of the Influenza B Infections pipeline landscape.

More information

Myasthenia Gravis Market Share, Size, Definition, Treatment, Pipeline Review, H2 2016

Myasthenia Gravis Market Share, Size, Definition, Treatment, Pipeline Review, H2 2016 Global Markets Direct's, 'Myasthenia Gravis - Pipeline Review, H2 2016', provides an overview of the Myasthenia Gravis pipeline landscape.

More information

Nonstructural Protein 4B (NS4B) Market Share, Definition, Treatment, Symptoms, Causes, Pipeline Review, H1 2016

Nonstructural Protein 4B (NS4B) Market Share, Definition, Treatment, Symptoms, Causes, Pipeline Review, H1 2016 Global Markets Direct's, 'Nonstructural Protein 4B (NS4B) - Pipeline Review, H1 2016', provides in depth analysis on Nonstructural Protein 4B (NS4B) targeted pipeline therapeutics. Visit Us @ http://www.radiantinsights.com/research/nonstructural-protein-4b-ns4b-pipeline-review-h1-2016

More information